Cargando…

Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification

INTRODUCTION: Accurate determination of human epidermal growth factor receptor 2 (HER2) status is essential for optimal patient management with trastuzumab (Herceptin). However, standard guidelines do not specify a particular commercial kit, antibody or probe for testing, and discrepancies arise fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cayre, Anne, Mishellany, Florence, Lagarde, Nicole, Penault-Llorca, Frédérique
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242659/ https://www.ncbi.nlm.nih.gov/pubmed/17908324 http://dx.doi.org/10.1186/bcr1770

Ejemplares similares

La recherche de la surexpression de la protéine et l'amplification du gène HER2 dans le cancer de l'estomac par immunohistochimie et Hybridation in Situ: expérience du CHU HASSAN II de Fès
por: El Fatemi, Hinde, et al.
Publicado: (2012)

aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer
por: Cayre, Anne, et al.
Publicado: (2003)

Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice
por: Dupouy, Sandra, et al.
Publicado: (2014)

Is There a Relationship between Ovarian Epithelial Dysplasia and Infertility?
por: Chene, Gautier, et al.
Publicado: (2012)

Testing algorithm for identification of patients with TRK fusion cancer
por: Penault-Llorca, Frédérique, et al.
Publicado: (2019)

Determining the SARS-CoV-2 Anti-Spike Cutoff Level Denoting Neutralizing Activity Using Two Commercial Kits
por: El-Ghitany, Engy Mohamed, et al.
Publicado: (2022)

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
por: Rüschoff, Josef, et al.
Publicado: (2010)

Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer
por: Guiu, S, et al.
Publicado: (2010)

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study
por: van de Vijver, Marc, et al.
Publicado: (2007)

Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer
por: El Guerrab, Abderrahim, et al.
Publicado: (2011)

Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer
por: El Guerrab, Abderrahim, et al.
Publicado: (2017)

Application of CPI cutoff value based on parentage testing of duos and trios typed by four autosomal kits
por: Gao, Hongmei, et al.
Publicado: (2019)

Non-Biopsy Serology-Based Diagnosis of Celiac Disease in Adults Is Accurate with Different Commercial Kits and Pre-Test Probabilities
por: Ylönen, Venla, et al.
Publicado: (2020)

Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
por: Wang, Yuefeng, et al.
Publicado: (2017)

BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells
por: Privat, Maud, et al.
Publicado: (2014)

Use of a recombinase polymerase amplification commercial kit for rapid visual detection of Pasteurella multocida
por: Zhao, Guimin, et al.
Publicado: (2019)

Comparison of seven single cell whole genome amplification commercial kits using targeted sequencing
por: Biezuner, Tamir, et al.
Publicado: (2021)

Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
por: Scheel, Andreas H., et al.
Publicado: (2018)

Applicability of commercial clinical chemistry test kits for horse serum
por: Megerssa, Yoseph Cherinet, et al.
Publicado: (2021)

How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
por: Piec, Isabelle, et al.
Publicado: (2016)

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
por: Ng, Charlotte KY, et al.
Publicado: (2015)

Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy
por: Cook, Michael J, et al.
Publicado: (2016)

HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients
por: Tuefferd, Marianne, et al.
Publicado: (2007)

Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker
por: Faugeras, Eve, et al.
Publicado: (2022)

Morphological and Immunohistochemical Study of Ovarian and Tubal Dysplasia Associated with Tamoxifen
por: Chene, G., et al.
Publicado: (2014)

Performance and Application of Commercially Available Loop-Mediated Isothermal Amplification (LAMP) Kits in Malaria Endemic and Non-Endemic Settings
por: Morris, Ulrika, et al.
Publicado: (2021)

Assessment of ceftiofur residues in cow milk using commercial screening test kits
por: Durel, Luc, et al.
Publicado: (2019)

What’s in a commercial meal kit? Structured review of Australian meal kits
por: McKay, Fiona H
Publicado: (2023)

From Targeting Somatic Mutations to Finding Inherited Cancer Predispositions: The Other Side of the Coin
por: Pujol, Pascal, et al.
Publicado: (2019)

Comparative Evaluation of Six Commercialized Multiplex PCR Kits for the Diagnosis of Respiratory Infections
por: Pillet, Sylvie, et al.
Publicado: (2013)

Comparative Assessment of the Sensitivity of Ten Commercial Rapid Diagnostic Test Kits for the Detection of Plasmodium
por: Gendrot, Mathieu, et al.
Publicado: (2022)

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis
por: Gay‐Bellile, Mathilde, et al.
Publicado: (2016)

P-gp expression in brown trout erythrocytes: evidence of a detoxification mechanism in fish erythrocytes
por: Valton, Emeline, et al.
Publicado: (2013)

Added Value of HER-2 Amplification Testing by Multiplex Ligation-Dependent Probe Amplification in Invasive Breast Cancer
por: Kuijpers, Chantal C. H. J., et al.
Publicado: (2013)

Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
por: Siena, S, et al.
Publicado: (2018)

The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay
por: Choi, Moon Suk, et al.
Publicado: (2018)

The use and abuse of commercial kits used to detect autoantibodies
por: Fritzler, Marvin J, et al.
Publicado: (2003)

Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen
por: Basu, Samar, et al.
Publicado: (2015)

Comparison of gluten recovery in gluten-incurred buckwheat flour using different commercial test kits
por: Alvarez, Pedro A., et al.
Publicado: (2013)

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
por: Agersborg, Sally, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lko71ml69s5t55h4fisfsspib3